Humana Inc (HUM) stock

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 9/3040% above fair value

$414.50−3.06 (-0.73%)

Close on Oct 30, 2026Market cap $49.77BP/E 39.1Yield 0.85%

Earnings

Humana's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 4, 2026

Q3 FY2026 · estimated, before the open

Revenue, Q2 FY2026

$40.87B

+26.2% on a year earlier

Adjusted EPS, Q2 FY2026

$7.61

$6.27 a year earlier

Latest guidance

Lowered

Jul 29, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Humana's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2026ended Sep 30, 2026	Nov 4, 2026Expected	–	–	–	–	–
Q2 FY2026ended Jun 30, 2026	Jul 29, 2026before the open	$40.87B	+26.2%	$5.73	$7.61	Release
Q1 FY2026ended Mar 31, 2026	Apr 29, 2026before the open	–	–	$9.83	$10.31	Release
Q4 FY2025ended Dec 31, 2025	Feb 11, 2026before the open	$32.52B	–	-$6.61	-$3.96	Release
Q3 FY2025ended Sep 30, 2025	Nov 5, 2025before the open	$32.65B	+11.1%	$1.62	$3.24	Release
Q2 FY2025ended Jun 30, 2025	Jul 30, 2025before the open	$32.39B	+9.6%	$4.51	$6.27	Release
Q1 FY2025ended Mar 31, 2025	Apr 30, 2025before the open	$32.11B	+8.4%	$10.30	$11.58	Release
Q4 FY2024ended Dec 31, 2024	Feb 11, 2025before the open	–	–	-$5.76	-$2.16	Release
Q3 FY2024ended Sep 30, 2024	Oct 30, 2024before the open	$29.40B	+11.3%	$3.98	$4.16	Release
Q2 FY2024ended Jun 30, 2024	Jul 31, 2024before the open	$29.54B	+10.4%	$5.62	$6.96	Release
Q1 FY2024ended Mar 31, 2024	Apr 24, 2024before the open	$29.61B	+10.7%	$6.11	$7.23	Release
Q4 FY2023ended Dec 31, 2023	Jan 18, 2024before the open	–	–	–	–	Filing
Q3 FY2023ended Sep 30, 2023	Nov 1, 2023before the open	$26.42B	+15.9%	$6.71	$7.78	Release
Q2 FY2023ended Jun 30, 2023	Aug 2, 2023before the open	$26.75B	+13.0%	$7.66	$8.94	Release
Q1 FY2023ended Mar 31, 2023	Apr 26, 2023before the open	$26.74B	+11.6%	$9.87	$9.38	Release
Q4 FY2022ended Dec 31, 2022	Feb 1, 2023before the open	$22.44B	+6.6%	-$0.12	$1.62	Release
Q3 FY2022ended Sep 30, 2022	Nov 2, 2022before the open	$22.80B	+10.2%	$9.39	$6.88	Release
Q2 FY2022ended Jun 30, 2022	Jul 27, 2022before the open	$23.66B	–	$5.48	$8.67	Release
Q1 FY2022ended Mar 31, 2022	Apr 27, 2022before the open	$23.97B	–	$7.29	$8.04	Release
Q4 FY2021ended Dec 31, 2021	Feb 2, 2022before the open	$21.05B	–	-$0.11	$1.24	Release
Q3 FY2021ended Sep 30, 2021	Nov 3, 2021before the open	$20.70B	–	$11.84	$4.83	Release
Q2 FY2021ended Jun 30, 2021	Jul 28, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 28, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 3, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 3, 2020before the open	–	–	–	–	Release
Q2 FY2020ended Jun 30, 2020	Aug 5, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Humana's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
GAAP EPSGAAP	FY2026	$6.52	$8.36	Lowered	Jul 29, 2026
Adjusted EPSnon-GAAP	FY2026	$9.00	$9.00	Reaffirmed	Jul 29, 2026
individual Medicare Advantage (MA) membership growth	FY2026	+25%	+25%	Reaffirmed	Jul 29, 2026
Insurance segment benefit ratioGAAP	FY2026	92.75%	–	New	Jul 29, 2026
Insurance segment benefit ratio	FY2026	92.75%	–	New	Apr 29, 2026

Guidance vs results

The last range Humana gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Adjusted EPS	$17.00	$17.13Σ4Q	Above range
FY2025	EPS (GAAP)	$12.26	$9.82Σ4Q	Below range
FY2025	Revenue	$128.00B	$129.66BΣ4Q	Above range

Guidance history

Every forecast Humana put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Jul 29, 2026	Adjusted EPS	FY2026	$9.00	Reaffirmed
Jul 29, 2026	GAAP EPS	FY2026	$6.52	Lowered
Jul 29, 2026	Insurance segment benefit ratio	FY2026	92.75%	New
Jul 29, 2026	individual Medicare Advantage (MA) membership growth	FY2026	+25%	Reaffirmed
Apr 29, 2026	Adjusted EPS	FY2026	$9.00	Reaffirmed
Apr 29, 2026	GAAP EPS	FY2026	$8.36	Lowered
Apr 29, 2026	Insurance segment benefit ratio	FY2026	92.75%	New
Apr 29, 2026	individual Medicare Advantage (MA) membership growth	FY2026	+25%	New
Feb 11, 2026	Adjusted basis	FY2026	$9.00	New
Feb 11, 2026	GAAP EPS	FY2026	$8.89	New
Nov 5, 2025	Adjusted EPS	FY2025	$17.00	Reaffirmed
Nov 5, 2025	GAAP EPS	FY2025	$12.26	Lowered
Nov 5, 2025	individual Medicare Advantage membership	FY2025	-425,000	Lowered
Nov 5, 2025	Insurance segment benefit ratio	FY2025	90.1% – 90.5%	Reaffirmed
Jul 30, 2025	Adjusted FY 2025 EPS	FY2025	$17.00	New
Jul 30, 2025	GAAP EPS	FY2025	$13.77	New
Jul 30, 2025	individual Medicare Advantage membership	FY2025	-500,000	New
Jul 30, 2025	CenterWell Primary Care net patient growth	FY2025	50,000 – 70,000	Raised
Jul 30, 2025	Insurance segment benefit ratio	FY2025	90.1% – 90.5%	New
Jul 30, 2025	consolidated revenues	FY2025	$128.00B	New
Apr 30, 2025	Adjusted FY 2025 EPS guidance	FY2025	$16.25	Reaffirmed
Apr 30, 2025	GAAP EPS	FY2025	$14.68	Lowered
Apr 30, 2025	individual Medicare Advantage annual membership decline	FY2025	550,000	New
Apr 30, 2025	Insurance segment benefit ratio	FY2025	90.1% – 90.5%	New
Feb 11, 2025	Adjusted basis EPS	FY2025	$16.25	Lowered
Feb 11, 2025	GAAP EPS	FY2025	$15.88	New
Oct 30, 2024	Adjusted EPS	FY2024	$16.00	Reaffirmed
Oct 30, 2024	GAAP EPS	FY2024	$12.89	Raised
Oct 30, 2024	individual Medicare Advantage annual membership growth	FY2024	265,000	New
Oct 30, 2024	Insurance segment benefit ratio	FY2024	90%	Reaffirmed
Jul 31, 2024	Adjusted EPS	FY2024	$16.00	Reaffirmed
Jul 31, 2024	GAAP EPS	FY2024	$12.81	Lowered
Jul 31, 2024	Insurance segment benefit ratio	FY2024	90%	Reaffirmed
Jul 31, 2024	individual Medicare Advantage annual membership growth	FY2024	+4.2%	Raised
Apr 24, 2024	Adjusted EPS	FY2024	$16.00	New
Apr 24, 2024	GAAP EPS	FY2024	$13.93	New
Apr 24, 2024	Insurance segment benefit ratio	FY2024	90%	New
Apr 24, 2024	individual Medicare Advantage annual membership growth	FY2024	+2.8%	New
Nov 1, 2023	Adjusted EPS	FY2023	$28.25	Reaffirmed
Nov 1, 2023	GAAP EPS	FY2023	$26.31	Lowered
Aug 2, 2023	Adjusted EPS	FY2023	$28.25	Reaffirmed
Aug 2, 2023	EPS	FY2023	$26.91	Lowered
Aug 2, 2023	Insurance segment benefit expense ratio	FY2023	86.3% – 87.3%	New
Aug 2, 2023	individual Medicare Advantage membership growth	FY2023	+18%	Raised
Apr 26, 2023	Adjusted EPS	FY2023	$28.25	Raised
Apr 26, 2023	GAAP EPS	FY2023	$27.88	Raised
Feb 1, 2023	Adjusted basis	FY2023	$28.00	New
Feb 1, 2023	Adjusted EPS	FY2025	$37.00	New
Feb 1, 2023	GAAP basis	FY2023	$27.57	New
Feb 1, 2023	individual Medicare Advantage membership growth	FY2023	625,000	Raised
Feb 1, 2023	growth over FY 2022 ending membership	FY2023	+13.7%	New
Nov 2, 2022	Adjusted EPS	FY2022	$25.00	Raised
Nov 2, 2022	EPS	FY2022	$23.27	Raised
Nov 2, 2022	individual Medicare Advantage membership growth	FY2023	325,000 – 400,000	New
Jul 27, 2022	Adjusted EPS	FY2022	$24.75	Raised
Jul 27, 2022	EPS	FY2022	$20.30	Lowered
Jul 27, 2022	individual Medicare Advantage membership growth	FY2022	150,000 – 200,000	Reaffirmed
Apr 27, 2022	Adjusted EPS	FY2022	$24.50	Raised
Apr 27, 2022	EPS	FY2022	$22.98	Lowered
Apr 27, 2022	individual Medicare Advantage membership growth	FY2022	150,000 – 200,000	New
Feb 2, 2022	Adjusted EPS	FY2022	$24.00	New
Feb 2, 2022	GAAP EPS	FY2022	$23.08	New
Nov 3, 2021	Adjusted EPS	FY2021	$20.50	New
Nov 3, 2021	GAAP EPS	FY2021	$23.67	New
Nov 3, 2021	individual Medicare Advantage membership growth	FY2021	450,000	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.